The demand for advanced Pathogen Detection Systems in Spain has seen a monumental shift following the global health crises and the tightening of EU-wide food safety and clinical regulations. As a primary exporter and specialized manufacturer, we understand that the Spanish market—ranging from the high-tech biotech hubs in Catalonia to the agricultural powerhouses in Andalusia—requires systems that are not only accurate but also fully compliant with CE-IVD marking and the EU In Vitro Diagnostic Regulation (IVDR 2017/746).
Spain's healthcare infrastructure, managed through the Sistema Nacional de Salud (SNS), is increasingly prioritizing rapid molecular diagnostics. Traditional culture methods, while reliable, are being replaced by automated Real-Time PCR (qPCR) and Microbial Identification Systems. Our factory provides the essential hardware that enables Spanish clinics and research centers to detect pathogens like Listeria monocytogenes, Salmonella, and respiratory viruses in a fraction of the time.
Detection Accuracy
EU Compliance
Technical Support
Global Certifications
Shenzhen BioX Medical Co., Ltd. represents the pinnacle of China's "Silicon Valley" of MedTech. By sourcing directly from our 9,000 sqm facility, Spanish distributors and healthcare providers gain a significant Information Gain and competitive edge. Our systems integrate cutting-edge optics and thermal cycling technology that are often 30-40% more cost-effective than locally sourced European brands, without compromising on E-E-A-T standards.
Located in Shenzhen, we have immediate access to the world's most robust electronics and medical component ecosystem, ensuring that our Pathogen Detection Systems use the latest semiconductor and sensor technology.
We provide localized software interfaces in Spanish and adapt our protocols to meet the specific diagnostic needs of the Spanish agrarian and veterinary sectors, such as specialized PCR kits for livestock common in the Extremadura region.
With established logistics routes, we offer DDP (Delivered Duty Paid) options and seamless customs clearance, ensuring that high-precision equipment arrives at your facility in Spain safely and on schedule.
In high-density tourist areas like the Balearic Islands and Costa del Sol, our portable systems are used for rapid Legionella testing in hotel water systems, ensuring guest safety and compliance with Spanish health ordinances.
Spanish exporters of olive oil, wine, and meat products utilize our Automated Microbial Identification to verify the absence of pathogens before shipping products across the EU, protecting the "Brand Spain" reputation.
From pet clinics in Madrid to large-scale poultry farms, our Veterinary PCR Systems provide rapid diagnosis of avian flu and common pet pathogens, supporting Spain's massive animal health sector.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
As we look toward the next decade, the integration of Artificial Intelligence (AI) with molecular diagnostics is the primary trend we are pioneering. AI algorithms are now being used to analyze complex qPCR fluorescence curves, reducing the margin of human error and providing Spanish clinicians with instantaneous results interpretation.